FDA Adverse Event Malfunction Summary report: N

ALARIS SECONDARY SET

MDR report key: 5894250 · Received August 22, 2016

Report

Report Number
9616066-2016-01126
Event Type
Malfunction
Date Received
August 22, 2016
Report Date
August 10, 2016
Manufacturer
CAREFUSION
Product Code
FPA
PMA / PMN Number
K053049
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

HOSPIRA 250ML BAG NDC 0409-7922-02, LOT 57-019-JT, 5% DEXTROSE INJECTION; HOSPIRA 100ML BAG NDC 0409-7923-37, LOT 63-119-JT, EXP 1 MAR 2018, 5% DEXTROSE INJECTION, THERAPY DATE UNK. THE CUSTOMER¿S REPORT OF A LEAK AT THE TEXIUM/SMARTSITE CONNECTION POINT WAS NOT CONFIRMED. THE SETS AND COMPONENTS WERE VISUALLY INSPECTED FOR OBVIOUS DAMAGE SUCH AS INCOMPLETE BONDING ENGAGEMENTS, CRACKS, KINKS, HOLES, AND TEARS. NO ANOMALIES OR EVIDENCE OF DAMAGE WAS OBSERVED. THE ACTUATOR TABS OF THE TEXIUM ADAPTORS WERE NOT DAMAGED. FUNCTIONAL AND PRESSURE TESTING WAS PERFORMED; NO LEAKING WAS OBSERVED. DUE TO THE DUAL THREAD FEATURE OF BOTH THE SMARTSITE AND TEXIUM LUERS MAKING TWO DIFFERENT CONNECTION/THREADING CONFIGURATIONS POSSIBLE, THE SETS WERE DISCONNECTED AND REATTACHED SUCH THAT THE SECOND THREADING CONFIGURATION WAS EMPLOYED. NO LEAKS WERE OBSERVED. EACH SET WAS THEN TESTED INDIVIDUALLY AND NO LEAKS WERE OBSERVED. THE ROOT CAUSE WAS NOT IDENTIFIED BECAUSE NO FAULT WAS FOUND WITH THE RETURNED SETS.

Additional Manufacturer Narrative · 1

ALTHOUGH REQUESTED, THE AFFECTED PRODUCT HAS NOT BEEN RECEIVED. A FOLLOW UP REPORT WILL BE SUBMITTED WITH INVESTIGATION RESULTS SHOULD THE DEVICES BE RECEIVED FOR EVALUATION.

Description of Event or Problem · 1

THE CUSTOMER REPORTED A LEAK WHERE THE TEXIUM CONNECTED TO A SMARTSITE DURING AN INFUSION OF DOXIL CHEMOTHERAPY. THERE WAS NO REPORT OF ANY PATIENT HARM.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
546415 ALARIS SECONDARY SET SET, SECONDARY, INTRAVASCULAR FPA CAREFUSION 10013364T

Patients

Seq Age Sex Outcome Treatment
1